Search company, investor...

About Cerus

Cerus provides INTERCEPT Blood System, a treatment designed for high throughput processing of platelets and plasma from whole blood and apheresis collections. INTERCEPT treatment is designed to deactivate for hepatitis B and C, HIV, West Nile virus, and bacteria, chikungunya, malaria, and dengue. It is based in Concord, California.

Headquarters Location

1220 Concord Avenue

Concord, California, 94520,

United States

Missing: Cerus's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cerus's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Cerus Patents

Cerus has filed 1 patent.

The 3 most popular patent topics include:

  • Transfusion medicine
  • Hematology
  • Blood
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/9/2019

10/18/2022

Vascular diseases, Neurological disorders, Neurosurgery, Rare diseases, Cerebrovascular diseases

Grant

Application Date

5/9/2019

Grant Date

10/18/2022

Title

Related Topics

Vascular diseases, Neurological disorders, Neurosurgery, Rare diseases, Cerebrovascular diseases

Status

Grant

Latest Cerus News

Global Apheresis Market Is Projected to Reach US$ 8.9 Billion by 2032, As Neurology to Comprise Key Application Area: Fact.MR Report

Nov 18, 2022

Some of the leading incumbent players and vendors working within the global apheresis market are Terumo Corporation, Fresenius Kabi AG, B. Braun Melsungen AG, NIKKISO Co., Ltd., Medica S. p. A., Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Cerus Corporation, Kawasumi Laboratories, Inc., and Therakos, Inc., among others. Key manufacturers of the apheresis market are constantly innovating to meet new challenges that are evolving daily. Prominent market players are focusing on a competitive market pricing strategy, which includes the installation of integrated systems along with high-end software. Apheresis companies are entering into collaborations and partnerships with governments and end-use industries for increasing the installation rate of apheresis systems. The growing acceptance of disposable apheresis kits due to their relatively low prices, has created abundant opportunities for manufacturers are witnessing positive demand for apheresis technology. In January 2020 - Fresenius Kabi inaugurated the expansion of the transfusion and apheresis disposables plant in the Dominican Republic. The company manufactures apheresis sets. These products are used, for example, to collect blood components such as platelets or plasma. Fresenius Kabi undertook the expansion to meet the rising demand for these high-quality disposables used for critically important donations. In September 2020 - NIKKISO CO., LTD. participated in the China Medical Equipment Fair (CMEF) & International Component Manufacturing Design Show (ICMD), a global exhibition for the medical devices market. It will take place in Shanghai from October 19-22, 2020 In August 2022 -- Haemonetics Corporation announced an agreement with Epic, a leading Electronic Health Record (EHR) system, to offer Haemonetics' SafeTrace Tx® blood bank information system to Epic's global network of hospitals. Get Full Access of This Premium Report- More Valuable Insights Available Fact.MR, in its new offering, presents an unbiased analysis of the apheresis market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2032. The study divulges essential insights on the Apheresis Market Analysis Repot By Technology (Centrifugation, Membrane Filtration), By Product (Devices, Disposables), By Application (Renal Diseases, Neurology, Haematology, Cancer, Autoimmune Diseases, Cardiovascular Diseases) By Region - Global Forecast 2022-2032 Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the technology sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions. Check out more related studies published by Fact.MR Research: Leukapheresis Products Market Insights  - An increase in blood donations, increasing endeavours by key companies in the leukapheresis market's industry, and frequent advancements in medical technology and research sciences are all major drivers of the Leukapheresis products market. During the projection period of 2021-2031, the market for leukapheresis products is predicted to rise at a blistering rate. The manufacturing and excessive sales of "Leukopaks," which are supplemented with high concentrations of lymphocytes incorporating leukapheresis products, are one of the clearest instances of demand drivers for leukapheresis product sales. Plasmapheresis Market Research  - The rising prevalence of autoimmune illnesses has resulted in an increase in demand for plasmapheresis around the world. The growing need for extracorporeal therapy is likely to positively impact the global autoimmune disorders market's growth. Type 1 diabetes, celiac disease, rheumatoid arthritis, temporal arteritis, and lupus are just a few of the autoimmune illnesses that are driving growing demand for plasmapheresis. Plasmapheresis is also utilised to treat sickle cell disease and different forms of neurotherapy. Adsorption Apheresis Devices Market Scope  - The market for adsorption apheresis devices is expected to grow significantly over the forecast period, owing to an increase in the number of patients suffering from blood-related, neurological, and other disease problems, as well as an increase in healthcare expenditure in each country to improve hospital infrastructures and healthcare management policies, and an increase in the number of hospitals, which is one of the major factors driving the market for adsorption apheresis devices. About Fact.MR Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That’s why focus on offering insights that can actually make a difference to bottom-lines. Specialties: Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership. Contact:

Cerus Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cerus Rank

Cerus Frequently Asked Questions (FAQ)

  • Where is Cerus's headquarters?

    Cerus's headquarters is located at 1220 Concord Avenue, Concord.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.